Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
10.60
-0.30 (-2.75%)
Jan 14, 2025, 4:00 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $17.50 million as of January 14, 2025. Its market cap has increased by 202.78% in one year.
Market Cap
17.50M
Enterprise Value
30.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.60
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 17.50M, a decrease of -98.26%. That is a compound annual growth rate of -65.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 10, 2025 | 17.50M | -3.54% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.87B |
| Veradigm | 1.61B |
| SS Innovations International | 1.38B |
| Nika Pharmaceuticals | 600.93M |
| Elite Pharmaceuticals | 533.60M |
| Glass House Brands | 441.09M |
| Northwest Biotherapeutics | 349.57M |
| Silence Therapeutics | 278.57M |